Home/Filings/4/A/0001213900-21-068104
4/A//SEC Filing

Dubin Daniel 4/A

Accession 0001213900-21-068104

CIK 0001822711other

Filed

Dec 29, 7:00 PM ET

Accepted

Dec 30, 4:00 PM ET

Size

7.5 KB

Accession

0001213900-21-068104

Insider Transaction Report

Form 4/AAmended
Period: 2021-12-23
Dubin Daniel
Director
Transactions
  • Conversion

    Class A Common Stock

    2021-12-23+30,00030,000 total
  • Conversion

    Class B Common Stock

    2021-12-2330,0000 total
    Exercise: $0.00Class A Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into shares of Class A Common Stock of the Issuer.

Documents

1 file

Issuer

PARDES BIOSCIENCES, INC.

CIK 0001822711

Entity typeother

Related Parties

1
  • filerCIK 0001820809

Filing Metadata

Form type
4/A
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 4:00 PM ET
Size
7.5 KB